Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.33
- Piotroski Score 7.00
- Grade Outperform
- Symbol (MCK)
- Company McKesson Corporation
- Price $499.04
- Changes Percentage (0.8%)
- Change $3.95
- Day Low $494.39
- Day High $501.75
- Year High $637.51
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
- Last Earnings 08/01/2024
- Ex-Dividend for 5/16 Dividend 08/30/2024
- Dividend Payable 10/01/2024
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $535.00
- High Stock Price Target $670.00
- Low Stock Price Target $257.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $22.39
- Trailing P/E Ratio 26.21
- Forward P/E Ratio 26.21
- P/E Growth 26.21
- Net Income $3.00 B
Income Statement
Quarterly
Annual
Latest News of MCK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
McKesson Corporation (MCK): One of the Best Stocks to Buy According to Larry Robbins
Larry Robbins' hedge fund, Glenview Capital, has seen success by investing in healthcare stocks, particularly those benefiting from Obamacare. McKesson Corporation is one of the top stocks to buy, kno...
By Yahoo! Finance | 2 days ago -
Green Bay's Xavier McKinney becomes first since merger to have INT in first 5 games with team
Green Bay's Xavier McKinney achieved a historic milestone by becoming the first NFL player since 1970 to have an interception in his first five games with a team. He intercepted a pass during the game...
By AP NEWS | 2 days ago -
Transcript: Ret. Gen. Frank McKenzie on "Face the Nation with Margaret Brennan," Oct. 6, 2024
Retired Gen. Frank McKenzie discusses the conflict in the Middle East on "Face the Nation" with Margaret Brennan. He predicts Israel's response to Iran's missile attack, highlighting various potential...
By CBS News | 3 days ago
